Φορτώνει......
Bone marrow derived mesenchymal stem cells pretreated with erythropoietin accelerate the repair of acute kidney injury
Abstract Background Mesenchymal stem cells (MSCs) represent a promising treatment option for acute kidney injury (AKI). The main drawbacks of MSCs therapy, including the lack of specific homing after systemic infusion and early cell death in the inflammatory microenvironment, directly affect the the...
Αποθηκεύτηκε σε:
Κύριοι συγγραφείς: | , , , , , , , , , , |
---|---|
Μορφή: | Artigo |
Γλώσσα: | Inglês |
Έκδοση: |
BMC
2020-11-01
|
Σειρά: | Cell & Bioscience |
Θέματα: | |
Διαθέσιμο Online: | http://link.springer.com/article/10.1186/s13578-020-00492-2 |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|